发明名称 |
Tumor vascular marker-targeted vaccines |
摘要 |
The present invention provides methods of immunizing a subject against a tumor, inhibiting tumor growth, inhibiting tumor recurrence, treating, suppressing the growth of, or decreasing the incidence of a tumor, overcoming tolerance to a tumor vasculature marker (TVM) in a subject comprising the step of administering a vaccine comprising a TVM or a nucleic acid encoding a TVM and related vaccines. The present invention also provides a method of targeting a tumor vasculature in a subject having a tumor comprising the step of contacting said subject with a labeled compound that binds a) a tumor vasculature marker (TVM) or b) a nucleic acid molecule encoding said TVM. |
申请公布号 |
US9290556(B2) |
申请公布日期 |
2016.03.22 |
申请号 |
US200913121638 |
申请日期 |
2009.09.29 |
申请人 |
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
发明人 |
Coukos George;Facciabene Andrea |
分类号 |
C07H21/04;A61K48/00;C07K14/47;A61K39/00;A61K51/10;C07K16/28 |
主分类号 |
C07H21/04 |
代理机构 |
Pearl Cohen Zedek Latzer Baratz LLP |
代理人 |
Cohen Mark S.;Pearl Cohen Zedek Latzer Baratz LLP |
主权项 |
1. A vaccine comprising a nucleic acid construct comprising a nucleic acid sequence encoding a tumor endothelial marker (TEM)-1 protein or immunogenic fragment thereof fused in frame to a nucleic acid sequence encoding the N-terminal domain of fragment C of tetanus toxoid (DOM). |
地址 |
Philadelphia PA US |